1 / 6

Biologics Market 2019 Size and Share Overview

Market Research Future (MRFR) recently furnished a report that predicts a lucrative future for global biologics market. The report further adds that the market will be reaching the valuation of USD 285,520.4 million by the end of 2023 and is on track to expand at a CAGR of 6.95% during the forecast period (2018-2023).

bhagyashribhole123
Télécharger la présentation

Biologics Market 2019 Size and Share Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biologics Market Research Report - Forecast to 2023 Global Industry Survey, Growth, Competitive Landscapeand Forecasts to 2023 CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

  2. Biologics Market Research Report - Forecast to 2023 Research Across Sectors to Give Impetus to Global Biologics Market 2023 • Market Research Future (MRFR) recently furnished a report that predicts a lucrative future for global biologics market. The report further adds that the market will be reaching the valuation of USD 285,520.4 million by the end of 2023 and is on track to expand at a CAGR of 6.95% during the forecast period (2018-2023). • Data experts are predicting that the biologics market is on track to find greener pastures with increasing efforts and collective investments made towards the development of biologics with certain applications. An investment of more than USD 1.5 bn has been made by top 10 pharmaceutical companies in the past five years, translating into capacity expansion along with a rise in research and development. Numerous drug companies are earning massive profits due to premium prices that increase their profit margins between 20.0% and 40.0%. a predominant factor that is transforming the market dynamics is the growing product approvals on account of biologic’s ability to successfully treat highly complex diseases, which had been almost impossible in earlier times. Browse Report Details @ https://www.marketresearchfuture.com/reports/biologics-market-1339 www.marketresearchfuture.com

  3. Biologics Market Research Report - Forecast to 2023 Segmentation: • The market for biologics is segmented on the basis of product, disease indication, and manufacturing. • The product-wise segments in the biologics market include monoclonal antibody, interleukins, vaccines, growth factors, gene therapy, and others. Monoclonal antibody market is poised to reach the size of USD 92,597.4 million at a CAGR of 3.44% during the assessment period. The growth of the market has been the result of the growing use of monoclonal antibodies (mAbs) for enhancing the immunity system. On the other hand, vaccines made for about 21% of the total market in the year 2017, and is growing at the fastest rate in the forthcoming years. It is on its way to exhibit 6.75% CAGR, and is predicted to reach the valuation of USD 66,743.5 million by the end of the review period. • Based on disease indication, the market has been considered for cancer, diabetes, rheumatoid arthritis, psoriasis/psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, Crohn’s disease, juvenile idiopathic arthropathy, cardiovascular diseases, and others. Among these, in 2018, cancer controlled close to 19.2% share of the biologics market, whereas the rheumatoid arthritis segment is expected to topple the cancer segment from the top position by 2023. The segment will be representing a CAGR of 8.78% in the coming years, on account of the rapid approval of diverse types of drugs by the regulatory agencies. • Manufacturing-wise, two major methods covered in the report are outsourced and in-house. Out of these, the latter will exhibit a higher growth rate as a result of the presence of pharmaceutical companies, especially emerging companies that are researching the formulations at a very cheap price. Also, the outsourced segment is deemed to garner revenue of almost USD 112,162.4 million by 2023. Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1339 www.marketresearchfuture.com

  4. Biologics Market Research Report - Forecast to 2023 Application & Major Players in this Research: Biologics Market Prominent Players: Sanofi (France), Pfizer Inc. (U.S.), Amgen (U.S.), F. Hoffman-La Roche AG (Switzerland), AbbVie Inc. (U.S.), Bayer AG (Germany), AstraZeneca (U.K.), GlaxoSmithKline Plc (U.K.), Novartis AG (Switzerland), Eli Lilly and Company (U.S.), are among some of the leading companies in the global biologics market. Five players out of these are at the top with over 70% share of the total market, which are Roche, AbbVie, Amgen, GSK and Pfizer. Get Discount @ https://www.marketresearchfuture.com/check-discount/1339 www.marketresearchfuture.com

  5. Biologics Market Research Report - Forecast to 2023 About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. www.marketresearchfuture.com

  6. MARKET RESEARCH FUTURE THANK YOU salesteam@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) www.marketresearchfuture.com

More Related